Prestige Consumer Healthcare (PBH) Gross Margin (2010 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Gross Margin came in at 55.52% in Q4 2025, up 5.0% year-on-year from 52.88% in Q4 2024, and little changed quarter-over-quarter from 55.3% in Q3 2025.
Prestige Consumer Healthcare (PBH) Gross Margin (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Gross Margin history runs 16 years deep, the most recent figure standing at 55.52% for Q4 2025.
- On a quarterly basis, Gross Margin rose 5.0% year-over-year to 55.52% in Q4 2025; TTM through Dec 2025 was 56.12%, a 100.0% increase from a year earlier, with the FY2025 full-year figure at 55.76%, up 28.0% from the prior year.
- Gross Margin steadied at 55.52% in Q4 2025 per PBH's latest filing, from 55.3% in the prior quarter.
- Across five years, Gross Margin topped out at 59.07% in Q2 2021 and bottomed at 53.79% in Q1 2023.
- The 5-year median for Gross Margin is 55.71% (2022), against an average of 55.99%.
- Across the five-year window, Gross Margin slumped 242 bps in 2023 and jumped 253 bps in 2025, its largest moves.
- Year by year, Gross Margin stood at 56.49% in 2021, then fell by 3 bps to 54.59% in 2022, then rose by 2 bps to 55.86% in 2023, then dropped by 1 bps to 55.47% in 2024, then climbed by 0 bps to 55.52% in 2025.
- Per Business Quant, the three latest PBH Gross Margin figures stand at 55.52% (Q4 2025), 55.3% (Q3 2025), and 56.24% (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 55.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55.52% |
| Sep 30, 2025 | 55.30% |
| Jun 30, 2025 | 56.24% |
| Mar 31, 2025 | 57.34% |
| Dec 31, 2024 | 55.47% |
| Sep 30, 2024 | 55.46% |
| Jun 30, 2024 | 54.66% |
| Mar 31, 2024 | 54.81% |
| Dec 31, 2023 | 55.86% |
| Sep 30, 2023 | 55.89% |
| Jun 30, 2023 | 55.38% |
| Mar 31, 2023 | 53.79% |
| Dec 31, 2022 | 54.59% |
| Sep 30, 2022 | 55.66% |
| Jun 30, 2022 | 57.79% |
| Mar 31, 2022 | 55.77% |
| Dec 31, 2021 | 56.49% |
| Sep 30, 2021 | 57.10% |
| Jun 30, 2021 | 59.07% |
| Mar 31, 2021 | 57.64% |